Anavex Life Sciences Corp (AVXL)

[F1ash]

There seems to be a some sort of impediment to our communication process. See if this helps.



"Does it seem reasonable for an outside partner to pony up $100 million to run a phase 3 trial for an indication, (. . . ), that has a historical failure rate in phase 3 trials of the high 90%'s"

Alzheimer's R&D suffers as trial failure rate hits an 'astounding' 99.6% ... "

http://www.fiercebiotech.com/r-d/alzheimer-s-r-d-suffers-as-trial-failure-rate-hits-an-astounding-99-6